TEDMED 2013 Announces Final Speaker Lineup Of 60+ Experts Who Will Inspire Audiences Around The Globe To Think Differently About Medicine, Healthcare And Technology

WASHINGTON, April 10, 2013 -- TEDMED, www.TEDMED.com, the annual multi-disciplinary gathering where 1,500+ leaders from all sectors of society come together to explore the promise of technology and potential of human achievement in health and medicine, has announced its final speaker line up of 60+ thought leaders and performers who will be featured on the TEDMED 2013 stage.

The annual TEDMED conference will include 64 speakers divided among 10 sessions and will take place at the John F. Kennedy Center for the Performing Arts in Washington, DC from April 16-19, 2013. The following distinguished speakers and performers will challenge, inspire, enlighten and entertain audiences around the world:

TEDMED 2013 speakers and presenters include:

Amy Abernethy, M.D., Director, Center for Learning Health Care, Duke Clinical Research Institute. Topic: Can patient data have a second life?

David Agus, M.D., Professor of Medicine and Engineering, University of Southern California, Author, The End of Illness. Topic: What is cancer?

Sekou Andrews, Internationally Acclaimed Spoken Word Artist, Playwright, Actor, Poet. Topic: What happens when the data of health is inspired by the poetry of care?

Peter Attia , Founder and President, Nutrition Science Initiative (NuSI). Topic: Is the "obesity crisis" just a disguise for a deeper problem?

Ashley Atkinson, Co-Director, Keep Growing Detroit. Topic: Are we ready for a Declaration of Food Interdependence?

Sue Austin , Artist, Freewheeling. Topic: When is a wheelchair an ultra-light submarine?

Erin Barker (and Ben Lillie), Senior Producer, The Story Collider. Topic: What is the best medicine?

Kishi Bashi, Singer-Songwriter, Composer and Performing Artist. Topic: To get to the future, can we reinvent the past?

Eli Beer, Founder and President, United Hatzalah. Topic: How did volunteers save more than 40,000 lives in 3 minutes (each) last year?

Regina Benjamin, United States Surgeon General. Topic: Can joy be the key that unlocks the puzzle?

Amanda Bennett , Executive Editor, Bloomberg News; Author, The Cost of Hope. Topic: When death is the enemy, what is victory?

Afro Blue, Howard University's premier vocal jazz ensemble. Topic: Can cool jazz raise your temperature?

America Bracho , CEO and President, Latino Health Access. Topic: What happens when patients become leaders on the health team?

Larry Brilliant , President & CEO, Skoll Global Threats Fund. Topic: Ending Pandemics: How close are we today?

Jonathan Bush, Co-Founder, President, Chairman and CEO, athenahealth. Topic: For Profit & Non-Profits: Can this marriage be saved?

Francis S. Collins, Director of the National Institutes of Health. Topic: Can science take the next leap?

Mick Cornett, Mayor of Oklahoma City, Oklahoma. Topic: When is a Lose-Lose a Win-Win?

Zubin Damania, M.D., Director of Healthcare Development, Downtown Project Las Vegas. Topic: Are zombie doctors taking over America?

Laura Deming, Partner, The Longevity Fund. Topic: How can science and business team up for the long (health) haul?

Susan Desmond-Hellmann , Chancellor, Arthur and Toni Rembe Rock Distinguished Professor, University of California, San Francisco. Topic: Attention stressed out docs: Can the consumer be the "cavalry" that rescues you?

Elazer Edelman , Thomas D. and Virginia W. Cabot Professor, Health Sciences and Technology, MIT Professor of Medicine, Harvard Medical School; Director, Harvard-MIT Biomedical Engineering Center; Senior Physician, Brigham and Women's Hospital. Topic: The Big Bang in Medicine and Engineering – will the knowledge explosion actually hurt innovation across disciplines?

Deborah Estrin , Professor of Computer Science, Cornell Tech, NYC; Professor, Public Health, Weill Cornell Medical College; Co-founder, Open mHealth. Topic: What happens when each patient becomes their own "universe" of unique medical data?

Harvey Fineberg, President, Institute of Medicine. Topic: What is the U.S. health disadvantage?

Steve Gullans , Ph.D., Managing Director, Excel Venture Management. Topic: When is "safe dosing" a dangerous prescription?

Michael Hebb , Food Provocateur and Founder, One Pot. Topic: What happens when death is what's for dinner?

Danny Hillis, Inventor, Scientist, Engineer, Entrepreneur, and Author. Topic: What's the 21st century version of prevention?

Salvatore Iaconesi, Interaction Designer, Robotic Engineer, Artist & Hacker. Topic: Can a poet and a loving community make cancer a thing of beauty?

John Kheir, M.D., Staff Physician and Scientist, Cardiac Intensive Care Unit Department of Cardiology, Boston Children's Hospital Harvard Medical School. Topic: Why couldn't we just have given her intravenous oxygen?

Raghava KK, Multidisciplinary Contemporary Artist. Topic: What happens now…that I can read your brainwaves?

Isaac Kohane , Professor of Pediatrics and Health Sciences Technology, Harvard Medical School. Topic: How can every clinical visit be used to advance medical science?

Ben Lillie (and Erin Barker), Co-Founder and Director, The Story Collider. Topic: What is the best medicine?

Max Little, Wellcome Trust/MIT Fellow and Assistant Professor, Aston University; Visiting Assistant Professor, MIT. Topic: What's the new way to ask big questions in science?

John Maeda , President, Rhode Island School of Design. Topic: How can design principles lead to more discovery and better treatment?

The Manzari Brothers, Tap Dancers/Performers. Topic: How do we interpret that "fascinating rhythm?"

Elizabeth Marincola , President, Society for Science and the Public; Publisher, Science News. Topic: What happens when science, money, and freedom of information collide?

Christopher J.L. Murray , Institute Director, Institute for Health Metrics and Evaluation (IHME). Topic: What does a $100 million public health data revolution look like?

David Odde & Black Label Movement, Professor and Director of Undergraduate Studies, Department of Biomedical Engineering, University of Minnesota Dance Theatre. Topic: If truth is beauty, can art be science?

Sally Okun , VP Advocacy, Policy & Patient Safety, PatientsLikeMe. Topic: Does anyone in healthcare want to be understood?

Ryan Panchadsaram , Senior Advisor at the White House, Office of Science and Technology Policy. Topic: How do we move from health data to health dialog?

Richard Payne , Esther Colliflower Professor of Medicine and Divinity, Duke University. Topic: How does it end?

Mike Pazin , Program Director, Functional Genomics, Division of Genome Sciences, National Human Genome Research Institute. Topic: Can an "orchestra" of scientists find the hidden music in your DNA?

Michael E. Porter , Bishop William Lawrence University Professor, Harvard Business School. Topic: How can we improve health care if doctors don't know if they do any good?

Ramesh Raskar , Associate Professor, MIT Media Lab. Topic: How do we look at the future of health with both eyes?

Jessica Richman, Co-Founder, uBiome. Topic: Could a citizen scientist win a Nobel Prize?

Richard Simmons, Fitness personality and actor. Topic: How do I count my blessings every day?

Gary Slutkin , M.D., Founder and Executive Director of Cure Violence; Professor, Epidemiology and International Health, University of Illinois at Chicago School of Public Health. Topic: What if we treated violence like a contagious disease?

Larry Smarr , Professor, University of California, San Diego; Director, Calit2. Topic: Can you coordinate the dance of your body's 100 trillion microorganisms?

Jill Sobule, Songstress. Topic: How about a musical melody?

Andrew Solomon , Writer and lecturer on psychology, politics, and the arts; Winner of the National Book Award. Topic: How does an illness become an identity?

Kelli Swazey, Anthropologist. Topic: What happens when we welcome death in defining life?

Pritpal S Tamber, Founder, Optimising Clinical Knowledge Ltd. Topic: What's the human factor that lets innovation succeed?

Charity Tillemann-Dick, Singer. Topic: How does mortality inspire creativity?

Mariano Vazquez, Researcher, Barcelona Computing Center. Topic: How do I compute the body electric?

Victor Wang, Founder and CEO, GeriJoy Inc. Topic: How can helping you help me?

Washington Conservatory of Music, Pianists. Topic: What is the sound of E. Pluribus Unum?

H. Shaw Warren, M.D., Physician and Pediatrician, Massachusetts General Hospital; Associate Professor of Pediatrics, Harvard Medical School. Topic: Why do we use mice to study human diseases?

Rafael Yuste, Professor of Biological Sciences, Columbia University. Topic: When should science shoot for the moon?

Roni Zeiger, CEO, Smart Patients. Topic: Who is the real medical expert?

Innovation in Focus
In partnership with Big Think (www.bigthink.com), TEDMED will host a special two-hour program on Thursday, April 18, 2013 exploring the central question: What Drives Innovation in Healthcare? Leaders from both inside and outside of healthcare will focus on the innovation process in two guided discussions. Discussion I: Shifting the Curve From Start to Scale to Exit will be moderated by Juan Enriquez, Futurist, and distinguished panelists Michael Weintraub, CEO, Humedica; Dr. Giovanni Colella, CEO, Castlight Health; Nina Nashif, CEO, Healthbox; and Grant Verstandig, CEO, AudaxHealth.

Discussion II: Every Company is a Healthcare Company will examine how innovation is being driven from the outside – by both opportunity and necessity. Moderator Jeff DeGraff, Professor at the University of Michigan, will be joined by Jennifer Kurkoski, Director, Google's People & Innovation Lab (PiLab); Rick Valencia, Vice President and General Manager, Qualcomm Life; Dr. Marleece Barber, Chief Medical Officer, Director of Health and Wellness, Lockheed Martin; and Dr. Geeta Nayyar, Chief Medical Information Officer, AT&T ForHealth.

The Hive at TEDMED 2013 Will Foster Innovation in Healthcare With 50 Start Up Companies and 97 Entrepreneurs

The Hive, debuting at TEDMED 2013, is dedicated to exploring transformative innovations and inspiring entrepreneurs in health and medicine. Located on the South Plaza of the Kennedy Center in Washington, DC, The Hive will bring together a diverse community of independent start-ups, accelerators, government-run challenges, academically-led programs and labs run by Fortune 500 companies.

In association with the StartUp Health Network, TEDMED received over 250 applications for just 50 spots. With the help of a team of curators, 50 transformative new companies and the 97 entrepreneurs that represent them were selected to join the TEDMED community and share their innovative new products and services with TEDMED Delegates. A continued online conversation will foster the unexpected connections and new possibilities that emerge from four days of discovery at TEDMED 2013.

The Hive 50 includes the following start-ups: AchieveMint, AdhereTech, ActualMeds, Avado, Beyond Lucid Technologies, Brain Sentry, CarePlanners, Corengi, CrowdMed, Department of Veterans Affairs, Docphin, Empower Interactive, Galileo Analytics, GeckoCap, Global Center for Medical Innovation (GCMI), Health Leads, Health Tech Hatch, Healthify, Humetrix, iMPak Health, IntelligentM, Jintronix, Logical Images, Nanoly Bioscience, Neumitra, Neurotrack Technologies, New York eHealth Collaborative, Novocor Medical Systems, NudgeRx, nVision Medical, Omada Health, Open mHealth, Ovuline, PokitDok, QMedic, RxAnte, Science Exchange, Sense Health, Sensulin LLC, ShapeUp, SOMA Analytics, Spire, StarlingHealth, Transform Health, Uprise Medical, VentriNova, Inc., VG Bio, VIS, Wellframe, and Wello.

Great Challenges Day Uses Storytelling to Explore Complex Issues
On the afternoon of Friday, April 19th, on the George Washington University main campus in Washington, DC, TEDMED will host its first-ever Great Challenges Day (www.tedmed.com/greatchallengesday), a multi-disciplinary gathering of more than 500 TEDMED Delegates including medical professionals, technology experts, policymakers, non-profit leaders, big business leaders and academics. Using tools from the emerging discipline of medical and scientific storytelling, participants will collaborate to better understand and communicate the complexities of some of health and medicine's most complex and pressing challenges, from managing the obesity epidemic to addressing medical costs. Opening speakers for this event will be: Randy Olson, writer/director of the feature films, Flock of Dodos: The Evolution-Intelligent Design Circus and Sizzle: A Global Warming Comedy; and Ben Lillie and Erin Barker, Co-founder, Director and Senior Producer, respectively, of Story Collider, and Moth StorySLAM champions. Breakout groups will be facilitated by leadership from Booz Allen Hamilton, Edelman, George Washington University faculty, Innosight and Jump Associates.

Conference Simulcast Extends TEDMED's Reach to Global Audiences
Talks by each speaker will be globally simulcast from the Kennedy Center via TEDMEDLive. The simulcast is expected to reach more than 2,500 locations in 50 countries around the world, for an estimated total audience surpassing 100,000. Participating organizations include government health agencies such as the Centers for Disease Control and Prevention and the National Institutes of Health; research universities such as Stanford and Johns Hopkins; medical colleges such as Fukushima Medical University in Japan, University of Medicine and Pharmacy in Romania; and international non-profit organizations such as Research4Life and the World Health Organization. 

Health Activities to Include the "Smartphone Physical"
A range of related activities will demonstrate technology advances in health measurements. The Smartphone Physical will give hundreds of attendees a clinically relevant checkup using only smartphone-powered devices. TEDMED has partnered with Fitbit in Walk Around the World, a shared "quantified self" experiment. Each attendee will be outfitted with a Fitbit One™ that tracks their energy output and sleep patterns. Attendees can also use the Brainscope, an Emotiv portable EEG system that divines personality traits.

TEDMED Partners
The TEDMED conference and mission are generously supported by major partners, including some of the world's best-known companies and thought leaders in the realm of health and medicine: Booz Allen Hamilton, GE Healthymagination, Kaiser Permanente, Level 3, Johnson & Johnson, the Robert Wood Johnson Foundation, Target, Xerox, The California Endowment, and Panasonic.

Contributing Partners
Major Contributions provided by Steelcase, Nurture by Steelcase, Cisco and Fitbit.

TEDMEDLive Partners
TEDMEDLive is made possible through the generous support of The California Endowment, Level 3, Royalty Pharma, Florida Blue, Xerox, Cancer Treatment Centers of America, Celgene, Booz Allen Hamilton, Kaiser Permanente, Johnson & Johnson, and Panasonic.

TEDMED Talks and Updates
TEDMED.com makes all of its stage presentations available as videos at www.TEDMED.com at no cost after the conference concludes.

TEDMED issues monthly email bulletins. To subscribe, please send an email to: update@tedmed.com.

Follow TEDMED at Twitter via @TEDMED, and the Great Challenges at #greatchallenges.

An RSS feed of TEDMED news and video releases is available via the TEDMED Blog, blog.tedmed.com.

TEDMED, LLC is an independent organization operated under a special license from the nonprofit TED conference. TEDMED is the world's only TED-licensed event focused solely on innovation and breakthrough thinking across all of health and medicine. TEDMED 2012 featured 71 preeminent leaders in health, medicine, science, technology, business, government, academia, media and the arts, who spoke before a sold-out audience of more than 1,600 Delegates. Jay Walker has served as the Curator of TEDMED since 2011. Walker is also the founder of Priceline.com. For more information, please visit www.TEDMED.com.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.